King of Prussia, PA – Greenphire, the leading provider of payment technologies for the clinical trials industry, today announced that it has been included in the Inc. 5000 list of the fastest growing private companies in the U.S. for the third consecutive year. Based on a three-year growth rate of 317%, the company has been ranked in the top third, and joins a rare group of organizations that have demonstrated consistently high growth over such a sustained period. The complete 2015 Inc. 5000 list can be found athttp://www.inc.com/inc5000
Greenphire CEO Sam Whitaker, comments: “We are proud to have been named in the Inc. 5000 for the third year running, alongside many of the country’s most successful and innovative organizations. Our hat-trick of listings is testament to our fantastic team, and the relentless hard work and creativity they demonstrate on an ongoing basis to ensure that Greenphire continues to achieve year-over-year success.”
Since its inception in 2008, Greenphire’s exponential growth has propelled the company to become the industry’s leading provider of clinical payment technologies. The company’s groundbreaking web-payment solutions, which are utilized by many of the top 30 pharmaceutical and biotechnology companies, help sponsors and CROs to improve the financial health of their clinical trials by automating and tracking all transactions to patients, physicians and investigative sites throughout the trial lifecycle.
